Cargando…

Characteristic of IgA and IgG antibody response to SARS-CoV-2 infection in an Italian referral COVID-19 Hospital

INTRODUCTION: Antibody response plays a fundamental role in the natural history of infectious disease. A better understanding of the immune response in patients with SARS-CoV-2 infection could be important for identifying patients at greater risk of developing a more severe form of disease and with...

Descripción completa

Detalles Bibliográficos
Autores principales: Carnicelli, Annamaria, Fiori, Barbara, Ricci, Rosalba, Piano, Alfonso, Bonadia, Nicola, Taddei, Eleonora, Fantoni, Massimo, Murri, Rita, Cingolani, Antonella, Barillaro, Christian, Cutuli, Salvatore Lucio, Marchesini, Debora, Della Polla, Davide Antonio, Forte, Evelina, Fuorlo, Mariella, Di Maurizio, Luca, Amorini, Paola, Cattani, Paola, Franceschi, Francesco, Sanguinetti, Maurizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107418/
https://www.ncbi.nlm.nih.gov/pubmed/33970428
http://dx.doi.org/10.1007/s11739-021-02750-8
_version_ 1783689946103545856
author Carnicelli, Annamaria
Fiori, Barbara
Ricci, Rosalba
Piano, Alfonso
Bonadia, Nicola
Taddei, Eleonora
Fantoni, Massimo
Murri, Rita
Cingolani, Antonella
Barillaro, Christian
Cutuli, Salvatore Lucio
Marchesini, Debora
Della Polla, Davide Antonio
Forte, Evelina
Fuorlo, Mariella
Di Maurizio, Luca
Amorini, Paola
Cattani, Paola
Franceschi, Francesco
Sanguinetti, Maurizio
author_facet Carnicelli, Annamaria
Fiori, Barbara
Ricci, Rosalba
Piano, Alfonso
Bonadia, Nicola
Taddei, Eleonora
Fantoni, Massimo
Murri, Rita
Cingolani, Antonella
Barillaro, Christian
Cutuli, Salvatore Lucio
Marchesini, Debora
Della Polla, Davide Antonio
Forte, Evelina
Fuorlo, Mariella
Di Maurizio, Luca
Amorini, Paola
Cattani, Paola
Franceschi, Francesco
Sanguinetti, Maurizio
author_sort Carnicelli, Annamaria
collection PubMed
description INTRODUCTION: Antibody response plays a fundamental role in the natural history of infectious disease. A better understanding of the immune response in patients with SARS-CoV-2 infection could be important for identifying patients at greater risk of developing a more severe form of disease and with a worse prognosis. METHODS: We performed a cross-sectional analysis to determine the presence and the levels of both anti-SARS-CoV-2 IgG and IgA in a cohort of hospitalized patients with confirmed infection at different times in the natural history of the disease. Patients enrolled when admitted at the emergency department were prospectively followed up during hospital stay. RESULTS: Overall, 131 patients were considered with a total of 237 samples processed. Cross-sectional analysis showed that seroconversion for IgA seems to occur between days 6 and 15, while IgG response seems to occur slightly later, peaking at day 20 after symptoms onset. Both IgA and IgG were maintained beyond 2 months. Severe patients showed a higher IgA response compared with mild patients when analyzing optical density (8.3 versus 5.6, p < 0.001). Prospective analysis conducted on 55 patients confirmed that IgA appear slightly earlier than IgG. After stratifying for the severity of disease, both the IgA and IgG responses were more vigorous in severe cases. Moreover, while IgG tended to stabilize, there was a relevant decline after the first month of IgA levels in mild cases. CONCLUSION: IgA and IgG antibody response is closely related, although seroconversion for IgA occurs earlier. Both IgA and IgG are maintained beyond 2 months. Severe patients showed a more vigorous IgA and IgG response. IgA levels seem to decline after 1 month since the onset of symptoms in mild cases. Our results should be interpreted with cautions due to several limitations in our study, mainly the small number of cases, lack of data on viral load and clinical setting.
format Online
Article
Text
id pubmed-8107418
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-81074182021-05-10 Characteristic of IgA and IgG antibody response to SARS-CoV-2 infection in an Italian referral COVID-19 Hospital Carnicelli, Annamaria Fiori, Barbara Ricci, Rosalba Piano, Alfonso Bonadia, Nicola Taddei, Eleonora Fantoni, Massimo Murri, Rita Cingolani, Antonella Barillaro, Christian Cutuli, Salvatore Lucio Marchesini, Debora Della Polla, Davide Antonio Forte, Evelina Fuorlo, Mariella Di Maurizio, Luca Amorini, Paola Cattani, Paola Franceschi, Francesco Sanguinetti, Maurizio Intern Emerg Med Im - Original INTRODUCTION: Antibody response plays a fundamental role in the natural history of infectious disease. A better understanding of the immune response in patients with SARS-CoV-2 infection could be important for identifying patients at greater risk of developing a more severe form of disease and with a worse prognosis. METHODS: We performed a cross-sectional analysis to determine the presence and the levels of both anti-SARS-CoV-2 IgG and IgA in a cohort of hospitalized patients with confirmed infection at different times in the natural history of the disease. Patients enrolled when admitted at the emergency department were prospectively followed up during hospital stay. RESULTS: Overall, 131 patients were considered with a total of 237 samples processed. Cross-sectional analysis showed that seroconversion for IgA seems to occur between days 6 and 15, while IgG response seems to occur slightly later, peaking at day 20 after symptoms onset. Both IgA and IgG were maintained beyond 2 months. Severe patients showed a higher IgA response compared with mild patients when analyzing optical density (8.3 versus 5.6, p < 0.001). Prospective analysis conducted on 55 patients confirmed that IgA appear slightly earlier than IgG. After stratifying for the severity of disease, both the IgA and IgG responses were more vigorous in severe cases. Moreover, while IgG tended to stabilize, there was a relevant decline after the first month of IgA levels in mild cases. CONCLUSION: IgA and IgG antibody response is closely related, although seroconversion for IgA occurs earlier. Both IgA and IgG are maintained beyond 2 months. Severe patients showed a more vigorous IgA and IgG response. IgA levels seem to decline after 1 month since the onset of symptoms in mild cases. Our results should be interpreted with cautions due to several limitations in our study, mainly the small number of cases, lack of data on viral load and clinical setting. Springer International Publishing 2021-05-10 2022 /pmc/articles/PMC8107418/ /pubmed/33970428 http://dx.doi.org/10.1007/s11739-021-02750-8 Text en © Società Italiana di Medicina Interna (SIMI) 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Im - Original
Carnicelli, Annamaria
Fiori, Barbara
Ricci, Rosalba
Piano, Alfonso
Bonadia, Nicola
Taddei, Eleonora
Fantoni, Massimo
Murri, Rita
Cingolani, Antonella
Barillaro, Christian
Cutuli, Salvatore Lucio
Marchesini, Debora
Della Polla, Davide Antonio
Forte, Evelina
Fuorlo, Mariella
Di Maurizio, Luca
Amorini, Paola
Cattani, Paola
Franceschi, Francesco
Sanguinetti, Maurizio
Characteristic of IgA and IgG antibody response to SARS-CoV-2 infection in an Italian referral COVID-19 Hospital
title Characteristic of IgA and IgG antibody response to SARS-CoV-2 infection in an Italian referral COVID-19 Hospital
title_full Characteristic of IgA and IgG antibody response to SARS-CoV-2 infection in an Italian referral COVID-19 Hospital
title_fullStr Characteristic of IgA and IgG antibody response to SARS-CoV-2 infection in an Italian referral COVID-19 Hospital
title_full_unstemmed Characteristic of IgA and IgG antibody response to SARS-CoV-2 infection in an Italian referral COVID-19 Hospital
title_short Characteristic of IgA and IgG antibody response to SARS-CoV-2 infection in an Italian referral COVID-19 Hospital
title_sort characteristic of iga and igg antibody response to sars-cov-2 infection in an italian referral covid-19 hospital
topic Im - Original
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107418/
https://www.ncbi.nlm.nih.gov/pubmed/33970428
http://dx.doi.org/10.1007/s11739-021-02750-8
work_keys_str_mv AT carnicelliannamaria characteristicofigaandiggantibodyresponsetosarscov2infectioninanitalianreferralcovid19hospital
AT fioribarbara characteristicofigaandiggantibodyresponsetosarscov2infectioninanitalianreferralcovid19hospital
AT riccirosalba characteristicofigaandiggantibodyresponsetosarscov2infectioninanitalianreferralcovid19hospital
AT pianoalfonso characteristicofigaandiggantibodyresponsetosarscov2infectioninanitalianreferralcovid19hospital
AT bonadianicola characteristicofigaandiggantibodyresponsetosarscov2infectioninanitalianreferralcovid19hospital
AT taddeieleonora characteristicofigaandiggantibodyresponsetosarscov2infectioninanitalianreferralcovid19hospital
AT fantonimassimo characteristicofigaandiggantibodyresponsetosarscov2infectioninanitalianreferralcovid19hospital
AT murririta characteristicofigaandiggantibodyresponsetosarscov2infectioninanitalianreferralcovid19hospital
AT cingolaniantonella characteristicofigaandiggantibodyresponsetosarscov2infectioninanitalianreferralcovid19hospital
AT barillarochristian characteristicofigaandiggantibodyresponsetosarscov2infectioninanitalianreferralcovid19hospital
AT cutulisalvatorelucio characteristicofigaandiggantibodyresponsetosarscov2infectioninanitalianreferralcovid19hospital
AT marchesinidebora characteristicofigaandiggantibodyresponsetosarscov2infectioninanitalianreferralcovid19hospital
AT dellapolladavideantonio characteristicofigaandiggantibodyresponsetosarscov2infectioninanitalianreferralcovid19hospital
AT forteevelina characteristicofigaandiggantibodyresponsetosarscov2infectioninanitalianreferralcovid19hospital
AT fuorlomariella characteristicofigaandiggantibodyresponsetosarscov2infectioninanitalianreferralcovid19hospital
AT dimaurizioluca characteristicofigaandiggantibodyresponsetosarscov2infectioninanitalianreferralcovid19hospital
AT amorinipaola characteristicofigaandiggantibodyresponsetosarscov2infectioninanitalianreferralcovid19hospital
AT cattanipaola characteristicofigaandiggantibodyresponsetosarscov2infectioninanitalianreferralcovid19hospital
AT franceschifrancesco characteristicofigaandiggantibodyresponsetosarscov2infectioninanitalianreferralcovid19hospital
AT sanguinettimaurizio characteristicofigaandiggantibodyresponsetosarscov2infectioninanitalianreferralcovid19hospital